86 related articles for article (PubMed ID: 3882004)
1. Reduction of distress in hyperprolactinemia with bromocriptine.
Buckman MT; Kellner R
Am J Psychiatry; 1985 Feb; 142(2):242-4. PubMed ID: 3882004
[TBL] [Abstract][Full Text] [Related]
2. Effect of bromocriptine on affect and libido in hyperprolactinemia.
Koppelman MC; Parry BL; Hamilton JA; Alagna SW; Loriaux DL
Am J Psychiatry; 1987 Aug; 144(8):1037-41. PubMed ID: 3300375
[TBL] [Abstract][Full Text] [Related]
3. Prolactin, aggression and hostility: a discussion of recent studies.
Kellner R; Buckman MT; Fava M; Fava GA; Mastrogiacomo I
Psychiatr Dev; 1984; 2(2):131-8. PubMed ID: 6483849
[TBL] [Abstract][Full Text] [Related]
4. Bromocriptine improves reduced libido and potency in men receiving maintenance hemodialysis.
Muir JW; Besser GM; Edwards CR; Rees LH; Cattell WR; Ackrill P; Baker LR
Clin Nephrol; 1983 Dec; 20(6):308-14. PubMed ID: 6357576
[TBL] [Abstract][Full Text] [Related]
5. Borderline hyperprolactinemia in infertile women: evaluation of the prolactin response to thyrotropin releasing hormone and double-blind placebo-controlled treatment with bromocriptine.
Glazener CM; Kelly NJ; Hull MG
Gynecol Endocrinol; 1987 Dec; 1(4):373-8. PubMed ID: 3140587
[TBL] [Abstract][Full Text] [Related]
6. No effect of bromocriptine in acromegaly: a controlled trial.
Lindholm J; Riishede J; Vestergaard S; Hummer L; Faber O; Hagen C
N Engl J Med; 1981 Jun; 304(24):1450-4. PubMed ID: 7015129
[TBL] [Abstract][Full Text] [Related]
7. A double blind controlled study of the hormonal and clinical effects of bromocriptine in the polycystic ovary syndrome.
Buvat J; Buvat-Herbaut M; Marcolin G; Racadot A; Fourlinnie JC; Beuscart R; Fossati P
J Clin Endocrinol Metab; 1986 Jul; 63(1):119-24. PubMed ID: 3519644
[TBL] [Abstract][Full Text] [Related]
8. Bromocriptine for treatment of benign breast disease. A double-blind clinical trial versus placebo.
Parlati E; Polinari U; Salvi G; Giorlandino C; Liberale I; Fiorella G; Dell'Acqua S
Acta Obstet Gynecol Scand; 1987; 66(6):483-8. PubMed ID: 3321867
[TBL] [Abstract][Full Text] [Related]
9. Bromocriptine treatment of spasmodic torticollis. A double-blind crossover study.
Juntunen J; Kaste M; Iivanainen M; Ranta T; Seppälä M
Arch Neurol; 1979 Jul; 36(7):449-50. PubMed ID: 378199
[TBL] [Abstract][Full Text] [Related]
10. Improved sexual function in male haemodialysis patients on bromocriptine.
Bommer J; Ritz E; del Pozo E; Bommer G
Lancet; 1979 Sep; 2(8141):496-7. PubMed ID: 90217
[TBL] [Abstract][Full Text] [Related]
11. Bromocriptine in the treatment of hypertension.
Walden RJ; Hernandez J; Bhattacharjee P; Graham B; Prichard BN
Eur J Clin Pharmacol; 1986; 30(2):141-4. PubMed ID: 3519242
[TBL] [Abstract][Full Text] [Related]
12. A double blind trial of the prolactin inhibitor bromocriptine in painful benign breast disease.
Mansel RE; Preece PE; Hughes LE
Br J Surg; 1978 Oct; 65(10):724-7. PubMed ID: 361149
[TBL] [Abstract][Full Text] [Related]
13. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group.
Webster J; Piscitelli G; Polli A; Ferrari CI; Ismail I; Scanlon MF
N Engl J Med; 1994 Oct; 331(14):904-9. PubMed ID: 7915824
[TBL] [Abstract][Full Text] [Related]
14. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome.
Walters AS; Hening WA; Kavey N; Chokroverty S; Gidro-Frank S
Ann Neurol; 1988 Sep; 24(3):455-8. PubMed ID: 3067654
[TBL] [Abstract][Full Text] [Related]
15. Psychosomatic aspects of hyperprolactinemia.
Fava M; Fava GA; Kellner R; Buckman MT; Lisansky J; Serafini E; DeBesi L; Mastrogiacomo I
Psychother Psychosom; 1983; 40(1-4):257-62. PubMed ID: 6657880
[TBL] [Abstract][Full Text] [Related]
16. Effect of bromocriptine on antipsychotic drug-induced hyperprolactinemia: eight-week randomized, single-blind, placebo-controlled, multicenter study.
Lee MS; Song HC; An H; Yang J; Ko YH; Jung IK; Joe SH
Psychiatry Clin Neurosci; 2010 Feb; 64(1):19-27. PubMed ID: 19968833
[TBL] [Abstract][Full Text] [Related]
17. Prolactin-lowering effect of acute and once weekly repetitive oral administration of cabergoline at two dose levels in hyperprolactinemic patients.
Mattei AM; Ferrari C; Baroldi P; Cavioni V; Paracchi A; Galparoli C; Romano C; Spellecchia D; Gerevini G; Crosignani PG
J Clin Endocrinol Metab; 1988 Jan; 66(1):193-8. PubMed ID: 3275684
[TBL] [Abstract][Full Text] [Related]
18. Hyperprolactinemia in oligospermic Nigerian males: effect of bromocriptine treatment.
Modebe O
Int J Fertil Menopausal Stud; 1994; 39(2):95-9. PubMed ID: 8012447
[TBL] [Abstract][Full Text] [Related]
19. Bromocriptine and premenstrual tension: a clinical and hormonal study.
Andersch B; Hahn L
Pharmatherapeutica; 1982; 3(2):107-13. PubMed ID: 7201645
[TBL] [Abstract][Full Text] [Related]
20. Value of bromocriptine in unexplained primary infertility: a double-blind controlled trial.
Wright CS; Steele SJ; Jacobs HS
Br Med J; 1979 Apr; 1(6170):1037-9. PubMed ID: 376036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
